This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cutting-edge approaches to trial and study design, technology, sourcing, data disclosure and medical communications.

INDUSTRY REPORT: Patient-centricity in Clinical Trials

ArticleImage
To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.

Following a survey of our global database of clinical trial professionals, in collaboration with SCORR Marketing, this industry report reveals exclusive insights into the perceptions, practices and future expectations of patient-centricity in clinical trials. CROs, pharma, service providers, academia and patient groups split across North America, Europe and Asia are all represented, creating results that provide a ‘state of the industry’ picture.

The report explores the question is patient-centricity in clinical development a real commitment or just empty jargon? Across the industry, patient-centricity has increasingly garnered attention in recent years from the media, sponsors, CROs and other pharmaceutical service and technology providers. However, the industry lacks a common approach to patient-centricity, which makes it even more elusive to determine how patient-centric clinical development really is. Are sponsors and contract research organizations truly focused on patients and taking their preferences and needs into account? If so, how? If not, why not?

Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.

Log in or create an Informa Connect account to access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.